A study to evaluate effect of [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer's Disease patients in comparison with [18F]FDG PET
Latest Information Update: 07 Jun 2021
At a glance
- Drugs MK 6884 (Primary) ; Fludeoxyglucose F-18
- Indications Alzheimer's disease
- Focus Diagnostic use
- 22 Apr 2021 Results of MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimers Disease, presented at the 73rd Annual Meeting of the American Academy of Neurology
- 21 May 2020 New trial record
- 01 May 2020 Results presented at the 72nd Annual Meeting of the American Academy of Neurology